Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Hernia
Published in: Hernia 1/2013

01-02-2013 | Review

A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions

Authors: F. E. Primus, H. W. Harris

Published in: Hernia | Issue 1/2013

Login to get access

Abstract

Purpose

We used an evidence-based approach to determine whether the promotions and claims of superiority of biologic mesh over synthetic mesh use in ventral hernia repairs (VHRs) under contaminated conditions were sound and valid.

Methods

We searched the Medline database to specifically identify review articles relating to biologic mesh and VHR and critically reviewed these studies using an evidence-based approach.

Results

For the past 45 years, four clinical reviews and one systematic review have included biologic meshes as part of a larger discussion on available prosthetics for VHR. All reviews supported biologic mesh use, especially in the setting of contaminated fields. Yet, the primary literature included in these reviews and served as the basis for these conclusions consisted entirely of case series and case reports, which have the lowest level of evidence in determining scientific validity. Furthermore, the FDA has neither cleared nor approved this particular use.

Conclusions

The cumulative data regarding biologic mesh use in VHRs under contaminated conditions does not support the claim that it is better than synthetic mesh used under the same conditions. The highly promoted and at least moderately utilized practice of placing biologic mesh in contamination is being done outside of the original intended use, and a re-evaluation of or possible moratorium on biologic mesh use in hernia surgery is seriously warranted. Alternatively, an industry-sponsored national registry of patients in whom ventral hernia repairs involved biologic mesh would substantively add to our understanding regarding how these intriguing biomaterials are being used and their overall clinical efficacy.
Literature
1.
2.
3.
Basoglu M, Yildirgan MI, Yilmaz I, Balik A, Celebi F, Atamanalp SS, Polat KY, Oren D (2004) Late complications of incisional hernias following prosthetic mesh repair. Acta Chir Belg 104(4):425–428PubMed
4.
Morris-Stiff GJ, Hughes LE (1998) The outcomes of nonabsorbable mesh placed within the abdominal cavity: literature review and clinical experience. J Am Coll Surg 186(3):352–367PubMedCrossRef
5.
Hiles M, Record Ritchie RD, Altizer AM (2009) Are biologic grafts effective for hernia repair. Surg Innov 16(1):26–37PubMedCrossRef
6.
7.
Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, Kilbridge JF, Rosen M, Silverman RP, Vargo D (2010) Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 148(3):544–558. doi:10.​1016/​j.​surg.​2010.​01.​008 PubMedCrossRef
8.
9.
Rosen MJ (2010) Biologic mesh for abdominal wall reconstruction: a critical appraisal. Am Surg 76(1):1–6PubMed
10.
11.
Segan RD (2010) A response to “Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction” (Harth KC, Rosen MJ. Surg Innov. 2009;16:324–329) and discussion of the MAUDE (manufacturer and user facility device experience) database, FDA regulation of biologic implants, and evidence-based medicine. Surg Innov 17 (3):273-275; author reply 276. doi:10.​1177/​1553350610371214​
12.
13.
14.
Rosenburg W, Donald A (1995) Evidence based medicine: an approach to clinical problem-solving. Br Med J 310:1122–1126CrossRef
15.
Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312(7023):71–72PubMedCrossRef
16.
US Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence (Periodic updates, 2000–2003) Guide to clinical preventive services. 3rd edn. Agency for Healthcare Research and Quality, Rockville
17.
Petrisor BA, Bhandari M (2007) The heirarchy of evidence: levels and grades of recommendation. Indian J Orthoped 41:11–15CrossRef
18.
19.
Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, IJzermans JN, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 343(6):392–398. doi:10.​1056/​NEJM200008103430​603 PubMedCrossRef
20.
Penttinen R (2008) Mesh Repair of common abdominal hernias: a review on experimental and clinical studies. Hernia 12:337–344PubMedCrossRef
21.
Ghazi B, Deigni O, Yezhelyev M, Losken A (2011) Current options in the management of complex abdominal wall defects. Ann Plast Surg 66(5):488–492PubMedCrossRef
22.
23.
Patton JH Jr, Berry S, Kralovich KA (2007) Use of Human acellular dermal matrix in complex and contaminated abdominal wall reconstructions. Am J Surg 193(3):360–363PubMedCrossRef
24.
Diaz JJ Jr, Guy J, Berkes MB, Guillamondegui O, Miller RS (2006) Acellular dermal allograft for ventral hernia repair in the compromised surgical field. Am Surg 72(12):1181–1187 Discussion 1187–1188PubMed
25.
Schuster R, Singh J, Safadi BY et al (2006) The use of acellular dermal matrix for contaminated abdominal wall defects: wound status predicts success. Am J Surg 192(5):594–597PubMedCrossRef
26.
Catena F, Ansaloni L, Gazzotti F, Gagliardi S, Di Saverio S, D’Alessandro L, Pinna AD (2007) Use of porcine dermal collagen graft (Permacol) for hernia repair in contaminated fields. Hernia 11(1):57–60PubMedCrossRef
27.
Ueno T, Pickett LC, de la Fuente SG, Lawson DC, Pappas TN (2004) Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg 8(1):109–112PubMedCrossRef
28.
29.
30.
Trevino JM, Franklin ME Jr, Berghoff KR, Glass JL, Jaramillo EJ (2006) Preliminary results of a two-layered prosthetic repair for recurrent inguinal and ventral hernias combining open and laparoscopic techniques. Hernia 10(3):253–257. doi:10.​1007/​s10029-006-0085-3 PubMedCrossRef
31.
Diaz JJ Jr, Conquest AM, Ferzoco SJ, Vargo D, Miller P, Wu YC, Donahue R (2009) Multi-institutional experience using human acellular dermal matrix for ventral hernia repair in a compromised surgical field. Arch Surg 144(3):209–215. doi:10.​1001/​archsurg.​2009.​12 PubMedCrossRef
32.
33.
34.
35.
36.
Kolker AR, Brown DJ, Redstone JS, Scarpinato VM, Wallack MK (2005) Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation. Ann Plast Surg 55(1):36–41 Discussion 41–32PubMedCrossRef
37.
Butler CE, Langstein HN, Kronowitz SJ (2005) Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast Reconstr Surg 116(5):1263–1275 Discussion 1276–1267PubMedCrossRef
38.
39.
Liyanage SH, Purohit GS, Frye JN, Giordano P (2006) Anterior abdominal wall reconstruction with a Permacol implant. J Plast Reconstr Aesthet Surg 59(5):553–555PubMedCrossRef
40.
Tung CS, Zighelboim I, Scott B, Anderson ML (2006) Human acellular dermal matrix for closure of a contaminated gynecologic wound. Gynecol Oncol 103(1):354–356PubMedCrossRef
41.
Gupta A, Zahriya K, Mullens PL, Salmassi S et al (2007) Experience with two different biosynthetic mesh materials, Surgisis and Alloderm. Hernia 10:419–425CrossRef
42.
43.
Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, Ponsky J (2007) Use of acellular dermal matrix for complicated ventral hernia repair: does techique affect outcomes? J Am Coll Surg 205:600–654CrossRef
44.
Candage R, Jones K, Luchette FA, Sinacore JM, Vandevender D, Reed RL 2nd (2008) Use of human acellular dermal matrix for hernia repair: friend or foe? Surgery 144(4):703–711PubMedCrossRef
45.
Brown GL, Richardson JD, Malangoni MA, Tobin GR, Ackerman D, Polk HC Jr (1985) Comparison of prosthetic materials for abdominal wall reconstruction in the presence of contamination and infection. Ann Surg 201(6):705–711PubMedCrossRef
46.
Bleichrodt RP, Simmermacher RK, van der Lei B, Schakenraad JM (1993) Expanded polytetrafluoroethylene patch versus polypropylene mesh for the repair of contaminated defects of the abdominal wall. Surg Gynecol Obstet 176(1):18–24PubMed
47.
Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240(4):578–583 Discussion 583–575PubMed
48.
Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133(4):378–382PubMedCrossRef
49.
van Geffen H, Simmermacher RK, van Vroonhoven T, van der Werken C (2005) Surgical treatment of large contaminated abdominal wall defects. J Am Coll Surg 201:206–212PubMedCrossRef
50.
51.
Voyles CR, Richardson JD, Bland KI, Tobin GR, Flint LM, Polk HC Jr (1981) Emergency abdominal wall reconstruction with polypropylene mesh: short-term benefits versus long-term complications. Ann Surg 194(2):219–223PubMedCrossRef
52.
Jones JW, Jurkovich GJ (1989) Polypropylene mesh closure of infected abdominal wounds. Am Surg 55(1):73–76PubMed
53.
Paton BL, Novitsky YW, Zerey M, Sing RF, Kercher KW, Heniford BT (2007) Management of infections of polytetrafluoroethylene-based mesh. Surg Infect (Larchmt) 8(3):337–341. doi:10.​1089/​sur.​2006.​053 CrossRef
54.
Howes N, Chagla L, Thorpe M, McCulloch P (1997) Surgical practice is evidence based. Br J Surg 84:1220–1223PubMedCrossRef
55.
Wente M, Seiler C, Uhl W, Buchler M (2003) Perspectives of evidence-based surgery. Dig Surg 20:263–269PubMedCrossRef
56.
Harth K, Rosen J (2011) Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction. Surg Innov 16(4):324–329CrossRef
57.
58.
Armellino MF, De Stefano G, Scardi F et al (2006) Use of Permacol in complicated incisional hernia (in Italian). Chir Ital 58(5):627–630PubMed
Metadata
Title
A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions
Authors
F. E. Primus
H. W. Harris
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Hernia / Issue 1/2013
Print ISSN: 1265-4906
Electronic ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-012-1037-8

Other articles of this Issue 1/2013

Hernia 1/2013 Go to the issue

Case Report

Retroperitoneal hernia following radical cystectomy: case report

Review

Internal hernias through the falciform ligament: a case series and comprehensive literature review of an increasingly common pathology

Original Article

Closure of midline contaminated and recurrent incisional hernias with components separation technique reinforced with plication of the rectus muscles

ACKNOWLEDGEMENT TO REFEREES

Acknowledgement to referees 2012

Original Article

A technique for placement of a bioabsorbable prosthesis with fibrin glue fixation for reinforcement of the crural closure during hiatal hernia repair

Original Article

Biologic mesh use practice patterns in abdominal wall reconstruction: a lack of consensus among surgeons